World's Best Scientists 2026 revealed!
Kenneth W. Mahaffey

Kenneth W. Mahaffey

D-Index & Metrics

Medicine

D-Index
139
Citations
117604
World Ranking
1717
National Ranking
985

Kenneth W. Mahaffey publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Kenneth W. Mahaffey sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 934 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Kenneth W. Mahaffey D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Kenneth W. Mahaffey sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 139 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Kenneth W. Mahaffey is affiliated with Stanford University in the United States and contributes extensively to the field of medicine. Their work primarily focuses on endocrinology, diabetes, and metabolism, with additional research spanning cardiology and cardiovascular medicine, surgery, pulmonary and respiratory medicine, and molecular biology. The volume of publications reflects a specialization in diabetes treatment and management, pancreatic function related to diabetes, and cardiovascular outcomes.

The scientist has authored numerous papers, including notable recent works such as:

  • Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes, 2024, New England Journal of Medicine
  • Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials, 2022, The Lancet
  • 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants, 2020, Journal of the American College of Cardiology
  • Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery, 2021, New England Journal of Medicine
  • Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis, 2020, Journal of the American Heart Association

Frequent collaborators in their research include:

  • Vlado Perkovic
  • Hiddo J.L. Heerspink
  • Bruce Neal
  • Meg Jardine
  • Brendon L. Neuen

Their published articles often appear in prominent journals such as:

  • Journal of the American Society of Nephrology
  • Journal of the American College of Cardiology
  • Circulation
  • European Heart Journal
  • Diabetes Obesity and Metabolism

Kenneth W. Mahaffey's primary fields of study center around medicine, with a substantial body of work in the following subfields:

  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine
  • Molecular Biology

The main topics addressed in their research include:

  • Diabetes Treatment and Management
  • Pancreatic function and diabetes
  • Diabetes Management and Research
  • Atrial Fibrillation Management and Outcomes
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Health Systems, Economic Evaluations, Quality of Life
  • Peripheral Artery Disease Management

Best Publications

  • Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

    Manesh R. Patel;Kenneth W. Mahaffey;Jyotsna Garg;Guohua Pan

  • ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation

    Stefan K. James;Dan Atar;Luigi P. Badano;Carina Blomstrom Lundqvist

  • Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

    Lars Wallentin;Richard C. Becker;Andrzej Budaj;Christopher P. Cannon

  • Canagliflozin and cardiovascular and renal events in type 2 diabetes

    Bruce Neal;Vlado Perkovic;Vlado Perkovic;Kenneth W. Mahaffey;Dick de Zeeuw

  • Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

    Vlado Perkovic;Vlado Perkovic;Meg J. Jardine;Meg J. Jardine;Bruce Neal;Bruce Neal;Bruce Neal;Severine Bompoint

  • Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation

    Marco V Perez;Kenneth W Mahaffey;Haley Hedlin;John S Rumsfeld

  • Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

    James J Ferguson;Robert M Califf;Elliott M Antman;Marc Cohen

  • Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

    Matthew T. Roe;Paul W. Armstrong;Keith A.A. Fox;Harvey D. White

  • Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis

    Evolve Trial Investigators;Chertow Gm;Block Ga;Correa-Rotter R

  • Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events

    Deepak L. Bhatt;Gregg W. Stone;Kenneth W. Mahaffey;C. Michael Gibson

  • Impact of Bleeding Severity on Clinical Outcomes Among Patients With Acute Coronary Syndromes

    Sunil V. Rao;Kristi O’Grady;Karen S. Pieper;Christopher B. Granger

  • Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

    Pierluigi Tricoci;Zhen Huang;Claes Held;David J. Moliterno

  • 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)

    Karen A. Hicks;James E. Tcheng;Biykem Bozkurt;Bernard R. Chaitman

  • Comparison of an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease: A Randomized Trial

    Gregg W. Stone;Mark Midei;William Newman;Mark Sanz

  • ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

    Neena S. Abraham;Mark A. Hlatky;Elliott M. Antman;Deepak L. Bhatt

  • Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

    Keith A. A. Fox;Jonathan P. Piccini;Daniel Wojdyla;Richard C. Becker

  • ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents

    Deepak L. Bhatt;James Scheiman;Neena S. Abraham;Elliott M. Antman

  • Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: Results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) Trial

    Kenneth W Mahaffey;Joseph A Puma;N.Alejandro Barbagelata;Marcelo F DiCarli

  • Intravenous Platelet Blockade with Cangrelor during PCI

    Deepak L. Bhatt;A. Michael Lincoff;C. Michael Gibson;Gregg W. Stone

  • Myonecrosis After Revascularization Procedures

    Robert M. Califf;Alaa E. Abdelmeguid;Richard E. Kuntz;Jeffrey J. Popma

Frequent Co-Authors

Jonathan P. Piccini
Jonathan P. Piccini Duke University
Robert A. Harrington
Robert A. Harrington Cornell University
Harvey D. White
Harvey D. White Auckland City Hospital
Manesh R. Patel
Manesh R. Patel Duke University
Robert M. Califf
Robert M. Califf Duke University
Daniel E. Singer
Daniel E. Singer Harvard University
Bruce Neal
Bruce Neal George Institute for Global Health
Richard C. Becker
Richard C. Becker University of Cincinnati
Paul W. Armstrong
Paul W. Armstrong University of Alberta
Gregg C. Fonarow
Gregg C. Fonarow University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine? There are many related online degrees and pathways for those who wish to enter or advance within healthcare fields. Nursing remains one of the most accessible and in-demand options, offering varied routes for students of different backgrounds.

Those looking to become registered nurses can take advantage of cheapest bsn programs online, ensuring quality education without the high cost. For current registered nurses aiming to advance, the most affordable accredited online rn to bsn programs allow you to further your credentials without disrupting your work schedule.

If you already hold a nursing degree and wish to reach the highest levels of practice, consider the cheapest dnp programs online for a flexible and affordable doctoral education. Those from non-nursing backgrounds interested in a nursing career may opt for direct entry msn programs for non-nurses online, which offer a streamlined way to enter the field quickly.

These online programs make healthcare careers accessible and affordable, supporting your journey toward a role in medicine or nursing.

Best Scientists Citing Kenneth W. Mahaffey

Trending Scientists

Recently Published Articles